IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,806,000,000 | +302843.7% | 178,875 | +222.3% | 0.07% | +188.0% |
| Q2 2019 | $3,567,000 | -78.4% | 55,500 | -72.7% | 0.02% | -78.6% |
| Q1 2019 | $16,504,000 | +19.4% | 203,325 | -20.5% | 0.12% | 0.0% |
| Q4 2018 | $13,820,000 | +7.3% | 255,650 | +2.4% | 0.12% | +27.2% |
| Q3 2018 | $12,874,000 | +30.6% | 249,600 | +5.6% | 0.09% | +17.9% |
| Q2 2018 | $9,854,000 | +10.5% | 236,475 | +16.9% | 0.08% | +13.0% |
| Q1 2018 | $8,917,000 | – | 202,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |